Parnax Lab Ltd vs Zydus Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Parnax Lab Ltd is ₹ 160.2 as of 05 May 15:30 . The P/E Ratio of Parnax Lab Ltd changed from 15.7 on March 2022 to 10.7 on March 2025 . This represents a CAGR of -9.14% over 4 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 21.1 on March 2021 to 19.7 on March 2025 . This represents a CAGR of -1.36% over 5 years The Market Cap of Parnax Lab Ltd changed from ₹ 16.58 crore on March 2021 to ₹ 122.9 crore on March 2025 . This represents a CAGR of 49.28% over 5 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 45131 crore on March 2021 to ₹ 89122 crore on March 2025 . This represents a CAGR of 14.58% over 5 years The revenue of Parnax Lab Ltd for the Dec '25 is ₹ 63.91 crore as compare to the Sep '25 revenue of ₹ 63.23 crore. This represent the growth of 1.08% The revenue of Zydus Lifesciences Ltd for the Dec '25 is ₹ 6975 crore as compare to the Sep '25 revenue of ₹ 6232 crore. This represent the growth of 11.93% The ebitda of Parnax Lab Ltd for the Dec '25 is ₹ 6.68 crore as compare to the Sep '25 ebitda of ₹ 8.71 crore. This represent the decline of -23.31% The ebitda of Zydus Lifesciences Ltd for the Dec '25 is ₹ 1842 crore as compare to the Sep '25 ebitda of ₹ 2090 crore. This represent the decline of -11.85% The net profit of Parnax Lab Ltd changed from ₹ 3.99 crore to ₹ 2.72 crore over 7 quarters. This represents a CAGR of -19.66% The net profit of Zydus Lifesciences Ltd changed from ₹ 1463 crore to ₹ 965.1 crore over 7 quarters. This represents a CAGR of -21.18% The Dividend Payout of Parnax Lab Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 24.28 % on March 2021 to 19.16 % on March 2025 . This represents a CAGR of -4.63% over 5 years .

About Parnax Lab Ltd

Parnax Lab Limited, formerly Known as Krishna Deep Trade & Investment Limited was incorporated in August, 1982.
The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited with effect from July 19, 2012.
The Company engages in the business activities of manufacturing and export of Pharmaceutical Formulations.
Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company.
With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products.

About Zydus Lifesciences Ltd

Zydus Lifesciences Limited, initially known as Cadila Healthcare Limited was incorporated in May, 1995, which changed to Zydus Lifesciences Limited on February 24, 2022.
The Company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. The Company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products.

FAQs for the comparison of Parnax Lab Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Parnax Lab Ltd or Zydus Lifesciences Ltd?

Market cap of Parnax Lab Ltd is 184 Cr while Market cap of Zydus Lifesciences Ltd is 91,753 Cr

What are the key factors driving the stock performance of Parnax Lab Ltd and Zydus Lifesciences Ltd?

The stock performance of Parnax Lab Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Parnax Lab Ltd and Zydus Lifesciences Ltd?

As of May 5, 2026, the Parnax Lab Ltd stock price is INR ₹160.2. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹911.85.

How do dividend payouts of Parnax Lab Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Parnax Lab Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.